Biotech відкриті
[search 0]
більше

Download the App!

show episodes
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, former ...
 
I
Inside Biotech

1
Inside Biotech

Dr. Yewande Pearse, Kathy Grotsch, Ananta Wadhwa

Unsubscribe
Unsubscribe
Щомісяця
 
Inside Biotech is an exciting new podcast from BCLA, which focuses on the science behind SoCals most innovative new biotech companies. This monthly podcast, hosted by Dr. Yewande Pearse, Media & Marketing Associate at BCLA, is the perfect way for LA’s biotech community to stay informed about current progress and developments, and features conversations with scientists, entrepreneurs, and investors about the cutting edge science that goes on inside their companies. On Inside Biotech, science ...
 
San Diego has grown into one of the largest biotechnology hubs in the United States with some very talented people doing very exciting things. Come along with me as I explore the world of biotech, meet some interesting people, and maybe even learn a thing or two. Oh wait… did I mention there will be beer?
 
Interviews with the researchers, founders, and investors of the BioTech industry. An insiders look into what is going on in the world of BioTech, from curing aging to psychedelic therapy, we interview the game changers of the industry. The unsung hero's that are moving the industry forward in a significant way. The world is going to be a vastly different place in the next 10-20 years because of what's happening in the BioTech industry right now.Human civilization will move forward farther, f ...
 
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
 
Loading …
show series
 
As 2022 continues, the sentiment within biotech remains poor. The poor performance of large tech companies like $NFLX and $PTON has caused everything to slide. On this week's episode, Agustin discusses what the future may look like within biotech and explains why $XBI continues to slide and why $LPTX is still compelling despite questions around saf…
 
As Allan Shaw likes to say, "there have never been so many people with their hands out, and there has never been so much money to go around." But how sustainable is this seemingly perennial boom in the biotech capital markets? Will the road go on forever and the party never end, or are there signs of a slowdown on the horizon? Shaw once again joins…
 
Dr. Michelle Ols is a Director and the Head of Cell Therapy at Obsidian Therapeutics. Obsidian Therapeutics is a private, Cambridge-based biotech company focused on the development of engineered cell and gene therapies for a range of indications. Obsidian has also pioneered their proprietary cytoDRiVE™ technology platform that leverages drug-respon…
 
One of the criticisms of farmers is that they fail to engage the public to show what they do. It is understandable, their days are busy, competition is stiff, and farming selects for folks [...] The post 328 – The Importance of Telling Ag’s Story first appeared on Talking Biotech Podcast.Kevin M. Folta
 
We are excited to welcome you to The Biotech Project. On our launch episode we introduce your hosts and discuss what the project is and our plans for upcoming episodes. Visit us at www.thebiotechproject.com to subscribe and follow us so you will always know when we release new information and episodes.…
 
CRISPR is an exciting space, with a number of companies finally sharing early clinical data in 2021. NTLA benefitted the most from this by doubling in valuation after data release, while the other CRISPR companies continue to trend lower in the XBI bear market. Caribou Biosciences is one of the smaller EV CRISPR companies with their first clinical …
 
Caroline O’Driscoll is a professional artist with advanced education in both the life sciences and visual communication. She collaborates with scientists, physicians, and other specialists to transform complex information into visual images that communicate to broad audiences. Her work has been utilized to support medical research, education, clini…
 
Exploring Mining Podcast Episode 241 - News from (TSXV: OTGO) (TSXV: FOR) (Frankfurt: 5QN) (NYSE: RIO) (NYSE: TRQ) (NYSE: GOLD) (TSXV: BAU)
 
One of the criticisms of farmers is that they fail to engage the public to show what they do. It is understandable, their days are busy, competition is stiff, and farming selects for folks [...] The post 328 – The Importance of Telling Ag’s Story first appeared on Talking Biotech Podcast.Kevin M. Folta
 
Cleantech and Climate Change Podcast - Hydrogen Fuel Cell Stocks in the Green - (NASDAQ: PLUG) (NYSE: BE) (TSX: DYA) (OTCQX: DYFSF) (NASDAQ: ENPH)
 
Peter is a 5th-year PhD student from the Pathobiology program at Johns Hopkins School of medicine. As part of Dr. Laura D. Wood’s lab, his thesis is focused on to understanding new mechanisms of invasion of pancreatic cancer by using patient derived samples in organoid models. The decision to follow the Academic or Industry path has been always in …
 
Exploring Mining Podcast 239 - (TSXV: OTGO) (TSXV: DEFN) (OTCQB: DFMTF) (NYSE: RIO) (NYSE: AU) (NYSE: AGI)
 
Despite the excitement behind JP Morgan's annual healthcare conference, $XBI still has taken a nose dive. On this week's episode, Agustin discuss how to find value among the wreckage that $XBI has generated and highlights in particular one company that he believes may get acquired.Biotech Bros LLC.
 
The JDRF's T1D Fund is exemplary of an indication-specific advocacy group's aggressive pursuit of a cure through venture philanthropy. Put simply, unlike traditional VC firms who entertain myriad and often diverse pitches from biotech startups, the T1D fund creates financial and advisory incentives for the biotechs in its portfolio to pursue candid…
 
Many diseases are rooted in the incorrect accumulation of proteins that regulate key cellular processes. Dozens of proteins control processes like cell division and cell death, and aberrant accumulation of these regulatory molecules [...] The post 327 – Attacking Disease by Targeting Proteins first appeared on Talking Biotech Podcast.…
 
Many diseases are rooted in the incorrect accumulation of proteins that regulate key cellular processes. Dozens of proteins control processes like cell division and cell death, and aberrant accumulation of these regulatory molecules [...] The post 327 – Attacking Disease by Targeting Proteins first appeared on Talking Biotech Podcast.…
 
Investor Ideas Potcasts #621, Cannabis News and Stocks on the Move; (Nasdaq: TLRY), (OTCQB: HCANF), (CSE: DELC) (OTCQB: DELCF), (CSE: XBRA) (OTC: XBRAF)
 
Exploring Mining Podcast #238 - (TSXV: OTGO) (NYSE: HL) (NYSE: IAG) (NYSE: NGD) (NYSE: EXK) (Nasdaq: SSRM)
 
Loading …

Короткий довідник

Google login Twitter login Classic login